Mid
A
ALNYAI Stock Diagnostic Report
Alnylam data support Amvuttra across ATTR patient groups, advance hypertension drug case
Alnylam's clinical data supported the efficacy of Onpattro in all ATTR patient populations and showed progress in the development of a hypertension treatment.
View Source Article ↗AI CATALYST SCORE75 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time